Cited by 105Organ Transplantation Techniques and OutcomesLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation

International liver transplantation consensus statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation

Open access
Tsochatzis, Emmanuel, Coilly, Audrey, Nadalin, Silvio, Levistky, Josh, Tokat, Yaman, Ghobrial, Mark, Klinck, John, Berenguer, Marina·2019·Transplantation

Abstract

Nonalcoholic steatohepatitis (NASH)-related cirrhosis has become one of the most common indications for liver transplantation (LT), particularly in candidates older than 65 years. Typically, NASH candidates have concurrent obesity, metabolic, and cardiovascular risks, which directly impact patient evaluation and selection, waitlist morbidity and mortality, and eventually posttransplant outcomes. The purpose of these guidelines is to highlight specific features commonly observed in NASH candidates and strategies to optimize pretransplant evaluation and waitlist survival. More specifically, the working group addressed the following clinically relevant questions providing recommendations based on the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system supported by rigorous systematic reviews and consensus: (1) Is the outcome after LT similar to that of other etiologies of liver disease? (2) Is the natural history of NASH-related cirrhosis different from other etiologies of end-stage liver disease? (3) How should cardiovascular risk be assessed in the candidate for LT? Should the assessment differ from that done in other etiologies? (4) How should comorbidities (hypertension, diabetes, dyslipidemia, obesity, renal dysfunction, etc.) be treated in the candidate for LT? Should treatment and monitoring of these comorbidities differ from that applied in other etiologies? (5) What are the therapeutic strategies recommended to improve the cardiovascular and nutritional status of a NASH patient in the waiting list for LT? (6) Is there any circumstance where obesity should contraindicate LT? (7) What is the optimal time for bariatric surgery: before, during, or after LT? (8) How relevant is donor steatosis for LT in NASH patients?

Integrity signals

Registry

Crossref · 10.1097/tp.0000000000002433

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tsochatzis, E., Coilly, A., Nadalin, S., Levistky, J., Tokat, Y., Ghobrial, M., Klinck, J., & Berenguer, M.
Affiliations
  • The Royal Free Hospital (GB)
  • Université Paris-Sud (FR)
  • Universitätsklinikum Tübingen (DE)
  • Northwestern University (US)
  • Istanbul Florence Nightingale Hospital (TR)
  • Sherrie and Alan Conover Center for Liver Disease and Transplantation, Weill Cornell Medical College, Houston, TX.
  • University of Cambridge (GB)
  • Universitat de València (ES)
Corresponding author
Berenguer, Marina
Venue
Transplantation
Published
2019-01
Volume
103
Issue
1
Pages
45-56
ISSN
  • 0041-1337 (ISSN-L)
  • 1534-6080
OpenAlex
W2889466260
Cited by
105
References
125
Citations by year
2026: 6 · 2025: 5 · 2024: 16 · 2023: 12 · 2022: 17 · 2021: 20 · 2020: 14 · 2019: 12 · 2018: 3
FWCI
12.74
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Transplantation (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
nonalcoholic steatohepatitis, liver transplantation, end-stage liver disease, pre-transplant evaluation, waitlist survival, cardiovascular risk assessment, obesity, comorbidity management, bariatric surgery, post-transplant outcomes
MeSH terms
Cardiovascular Diseases, Consensus Statements as Topic, Humans, Liver Cirrhosis, Obesity, Tissue and Organ Procurement, Time Factors, Waiting Lists, Comorbidity, Liver Transplantation, Treatment Outcome, Consensus, Bariatric Surgery, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review